Novo Nordisk | Umlaufvermögen

Current Assets Veränderung Datum
ANI Pharmaceuticals USD 540.56M 20.74M 2024-03
Aurora Cannabis CAD 406.53M 18.55M 2023-12
Bausch Health Companies USD 5.4B 200M 2024-03
Bristol-Myers Squibb USD 28.67B 1.04B 2024-03
Canopy Growth CAD 371.18M 26.1M 2024-03
Catalent USD 2.52B 47M 2024-03
Corcept Therapeutics USD 503.37M 44.73M 2024-03
Drreddys Laboratories INR 238.48B 20.78B 2023-12
Eli Lilly USD 25.19B 2.18B 2024-03
GlaxoSmithKline GBP 17.21B 1.44B 2024-03
Merck USD 31.44B 509M 2024-03
Novartis USD 26.45B 4.03B 2024-03
Novo Nordisk DKK 116.42B 23.22B 2024-03
Pacira USD 543.11M 33.12M 2024-03
Perrigo USD 2.81B 26.5M 2024-03
Prestige Brands USD 375.04M 18.74M 2024-03
Supernus Pharmaceuticals USD 544.32M 51.21M 2024-03
Zoetis USD 6.36B 16M 2024-03



Novo Nordisk Umlaufvermögen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jun 2024.